nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GRIN2A—melanoma	0.669	1	CbGaD
Glycine—GARS—hair follicle—melanoma	0.00439	0.0457	CbGeAlD
Glycine—GATM—hair follicle—melanoma	0.00417	0.0433	CbGeAlD
Glycine—SLC6A5—head—melanoma	0.00336	0.0349	CbGeAlD
Glycine—L-Cysteine—MGMT—melanoma	0.00307	0.542	CrCbGaD
Glycine—GLYATL2—head—melanoma	0.00286	0.0297	CbGeAlD
Glycine—SLC32A1—head—melanoma	0.00264	0.0274	CbGeAlD
Glycine—GSS—hair follicle—melanoma	0.00261	0.0271	CbGeAlD
Glycine—Aminolevulinic acid—SLC15A2—melanoma	0.0026	0.458	CrCbGaD
Glycine—GLRA3—head—melanoma	0.00255	0.0265	CbGeAlD
Glycine—SLC6A9—head—melanoma	0.00255	0.0265	CbGeAlD
Glycine—ALAS1—eye—melanoma	0.0024	0.025	CbGeAlD
Glycine—GLDC—mammalian vulva—melanoma	0.0024	0.025	CbGeAlD
Glycine—GCAT—skin of body—melanoma	0.00239	0.0248	CbGeAlD
Glycine—PIPOX—mammalian vulva—melanoma	0.00224	0.0233	CbGeAlD
Glycine—GARS—eye—melanoma	0.00219	0.0228	CbGeAlD
Glycine—GCAT—mammalian vulva—melanoma	0.00218	0.0226	CbGeAlD
Glycine—GARS—retina—melanoma	0.00217	0.0226	CbGeAlD
Glycine—GCSH—head—melanoma	0.00208	0.0216	CbGeAlD
Glycine—ALAS1—mammalian vulva—melanoma	0.00191	0.0198	CbGeAlD
Glycine—GARS—skin of body—melanoma	0.00191	0.0198	CbGeAlD
Glycine—SHMT2—eye—melanoma	0.00191	0.0198	CbGeAlD
Glycine—SHMT2—retina—melanoma	0.00189	0.0196	CbGeAlD
Glycine—SLC6A9—lymph node—melanoma	0.00178	0.0185	CbGeAlD
Glycine—GLRA2—head—melanoma	0.00176	0.0184	CbGeAlD
Glycine—GARS—mammalian vulva—melanoma	0.00174	0.0181	CbGeAlD
Glycine—SHMT1—eye—melanoma	0.00173	0.018	CbGeAlD
Glycine—GLDC—head—melanoma	0.00172	0.0179	CbGeAlD
Glycine—SHMT2—skin of body—melanoma	0.00166	0.0172	CbGeAlD
Glycine—PIPOX—head—melanoma	0.00161	0.0167	CbGeAlD
Glycine—GCAT—head—melanoma	0.00156	0.0162	CbGeAlD
Glycine—GPR18—lymph node—melanoma	0.00155	0.0161	CbGeAlD
Glycine—SHMT2—mammalian vulva—melanoma	0.00151	0.0157	CbGeAlD
Glycine—GCSH—lymph node—melanoma	0.00145	0.0151	CbGeAlD
Glycine—SHMT1—mammalian vulva—melanoma	0.00138	0.0143	CbGeAlD
Glycine—ALAS1—head—melanoma	0.00136	0.0142	CbGeAlD
Glycine—GSS—eye—melanoma	0.0013	0.0135	CbGeAlD
Glycine—GSS—retina—melanoma	0.00129	0.0134	CbGeAlD
Glycine—SLC16A10—neck—melanoma	0.00128	0.0133	CbGeAlD
Glycine—GARS—head—melanoma	0.00124	0.0129	CbGeAlD
Glycine—GRIN2C—head—melanoma	0.00122	0.0127	CbGeAlD
Glycine—GLDC—lymph node—melanoma	0.0012	0.0125	CbGeAlD
Glycine—GATM—head—melanoma	0.00118	0.0123	CbGeAlD
Glycine—GSS—skin of body—melanoma	0.00113	0.0118	CbGeAlD
Glycine—GCAT—lymph node—melanoma	0.00109	0.0113	CbGeAlD
Glycine—SHMT2—head—melanoma	0.00108	0.0113	CbGeAlD
Glycine—GSS—mammalian vulva—melanoma	0.00103	0.0108	CbGeAlD
Glycine—GLRB—head—melanoma	0.00101	0.0105	CbGeAlD
Glycine—SHMT1—head—melanoma	0.000985	0.0102	CbGeAlD
Glycine—ALAS1—lymph node—melanoma	0.000956	0.00994	CbGeAlD
Glycine—GARS—lymph node—melanoma	0.00087	0.00906	CbGeAlD
Glycine—GRIN2A—head—melanoma	0.000845	0.00879	CbGeAlD
Glycine—SLC36A1—head—melanoma	0.00084	0.00874	CbGeAlD
Glycine—GATM—lymph node—melanoma	0.000826	0.0086	CbGeAlD
Glycine—SHMT2—lymph node—melanoma	0.000757	0.00788	CbGeAlD
Glycine—SLC16A10—mammalian vulva—melanoma	0.000757	0.00787	CbGeAlD
Glycine—Encephalopathy—Carmustine—melanoma	0.000756	0.049	CcSEcCtD
Glycine—GSS—head—melanoma	0.000739	0.00769	CbGeAlD
Glycine—GLRB—lymph node—melanoma	0.00071	0.00738	CbGeAlD
Glycine—SHMT1—lymph node—melanoma	0.000689	0.00717	CbGeAlD
Glycine—Lung disorder—Temozolomide—melanoma	0.000663	0.0429	CcSEcCtD
Glycine—SLC36A1—lymph node—melanoma	0.000588	0.00612	CbGeAlD
Glycine—GSS—lymph node—melanoma	0.000518	0.00539	CbGeAlD
Glycine—Coma—Carmustine—melanoma	0.000444	0.0287	CcSEcCtD
Glycine—Chills—Vemurafenib—melanoma	0.000414	0.0268	CcSEcCtD
Glycine—Thrombophlebitis—Carmustine—melanoma	0.000407	0.0264	CcSEcCtD
Glycine—Thrombophlebitis—Temozolomide—melanoma	0.000393	0.0255	CcSEcCtD
Glycine—Back pain—Vemurafenib—melanoma	0.000388	0.0251	CcSEcCtD
Glycine—SLC16A10—lymph node—melanoma	0.000379	0.00394	CbGeAlD
Glycine—Thirst—Temozolomide—melanoma	0.000358	0.0232	CcSEcCtD
Glycine—Hyponatraemia—Carmustine—melanoma	0.000354	0.0229	CcSEcCtD
Glycine—Dehydration—Temozolomide—melanoma	0.000317	0.0205	CcSEcCtD
Glycine—Hypotension—Vemurafenib—melanoma	0.000306	0.0198	CcSEcCtD
Glycine—Lightheadedness—Docetaxel—melanoma	0.000279	0.0181	CcSEcCtD
Glycine—Thrombophlebitis—Docetaxel—melanoma	0.000262	0.0169	CcSEcCtD
Glycine—Chills—Bleomycin—melanoma	0.000251	0.0162	CcSEcCtD
Glycine—Hypersensitivity—Vemurafenib—melanoma	0.000241	0.0156	CcSEcCtD
Glycine—Visual disturbance—Docetaxel—melanoma	0.000239	0.0155	CcSEcCtD
Glycine—Visual impairment—Carmustine—melanoma	0.000235	0.0152	CcSEcCtD
Glycine—Chills—Dactinomycin—melanoma	0.000234	0.0151	CcSEcCtD
Glycine—Hyponatraemia—Docetaxel—melanoma	0.000227	0.0147	CcSEcCtD
Glycine—Visual impairment—Temozolomide—melanoma	0.000227	0.0147	CcSEcCtD
Glycine—Diarrhoea—Vemurafenib—melanoma	0.000224	0.0145	CcSEcCtD
Glycine—Dizziness—Vemurafenib—melanoma	0.000217	0.014	CcSEcCtD
Glycine—Chills—Temozolomide—melanoma	0.000211	0.0137	CcSEcCtD
Glycine—Dehydration—Docetaxel—melanoma	0.000211	0.0136	CcSEcCtD
Glycine—Vomiting—Vemurafenib—melanoma	0.000208	0.0135	CcSEcCtD
Glycine—Back pain—Carmustine—melanoma	0.000205	0.0133	CcSEcCtD
Glycine—Vision blurred—Carmustine—melanoma	0.0002	0.013	CcSEcCtD
Glycine—Oedema—Bleomycin—melanoma	0.000198	0.0129	CcSEcCtD
Glycine—Back pain—Temozolomide—melanoma	0.000198	0.0128	CcSEcCtD
Glycine—Nausea—Vemurafenib—melanoma	0.000195	0.0126	CcSEcCtD
Glycine—Vision blurred—Temozolomide—melanoma	0.000193	0.0125	CcSEcCtD
Glycine—Angina pectoris—Docetaxel—melanoma	0.000191	0.0124	CcSEcCtD
Glycine—Hypotension—Bleomycin—melanoma	0.000185	0.012	CcSEcCtD
Glycine—Oedema—Dactinomycin—melanoma	0.000185	0.012	CcSEcCtD
Glycine—Vertigo—Temozolomide—melanoma	0.000184	0.0119	CcSEcCtD
Glycine—Convulsion—Carmustine—melanoma	0.000184	0.0119	CcSEcCtD
Glycine—Convulsion—Temozolomide—melanoma	0.000178	0.0115	CcSEcCtD
Glycine—Oedema—Carmustine—melanoma	0.000173	0.0112	CcSEcCtD
Glycine—Pain—Bleomycin—melanoma	0.00017	0.011	CcSEcCtD
Glycine—Tachycardia—Carmustine—melanoma	0.000169	0.0109	CcSEcCtD
Glycine—Oedema—Temozolomide—melanoma	0.000167	0.0108	CcSEcCtD
Glycine—Hypotension—Carmustine—melanoma	0.000162	0.0105	CcSEcCtD
Glycine—Pain—Dactinomycin—melanoma	0.000158	0.0103	CcSEcCtD
Glycine—Urticaria—Bleomycin—melanoma	0.000158	0.0102	CcSEcCtD
Glycine—Rhinitis—Docetaxel—melanoma	0.000157	0.0102	CcSEcCtD
Glycine—Visual impairment—Docetaxel—melanoma	0.000151	0.00978	CcSEcCtD
Glycine—Pain—Carmustine—melanoma	0.000148	0.00959	CcSEcCtD
Glycine—Hypersensitivity—Bleomycin—melanoma	0.000146	0.00947	CcSEcCtD
Glycine—Pain—Temozolomide—melanoma	0.000143	0.00927	CcSEcCtD
Glycine—Chills—Docetaxel—melanoma	0.000141	0.00911	CcSEcCtD
Glycine—Hypersensitivity—Dactinomycin—melanoma	0.000136	0.00883	CcSEcCtD
Glycine—Urticaria—Temozolomide—melanoma	0.000133	0.00861	CcSEcCtD
Glycine—Back pain—Docetaxel—melanoma	0.000132	0.00855	CcSEcCtD
Glycine—Hypersensitivity—Carmustine—melanoma	0.000128	0.00827	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—melanoma	0.000127	0.0082	CcSEcCtD
Glycine—Vomiting—Bleomycin—melanoma	0.000126	0.00817	CcSEcCtD
Glycine—Hypersensitivity—Temozolomide—melanoma	0.000123	0.00799	CcSEcCtD
Glycine—Diarrhoea—Carmustine—melanoma	0.000119	0.00768	CcSEcCtD
Glycine—Convulsion—Docetaxel—melanoma	0.000118	0.00765	CcSEcCtD
Glycine—Nausea—Bleomycin—melanoma	0.000118	0.00763	CcSEcCtD
Glycine—Vomiting—Dactinomycin—melanoma	0.000118	0.00762	CcSEcCtD
Glycine—Dizziness—Carmustine—melanoma	0.000115	0.00742	CcSEcCtD
Glycine—Diarrhoea—Temozolomide—melanoma	0.000115	0.00742	CcSEcCtD
Glycine—Oedema—Docetaxel—melanoma	0.000111	0.00721	CcSEcCtD
Glycine—Dizziness—Temozolomide—melanoma	0.000111	0.00717	CcSEcCtD
Glycine—Vomiting—Carmustine—melanoma	0.00011	0.00713	CcSEcCtD
Glycine—Nausea—Dactinomycin—melanoma	0.00011	0.00712	CcSEcCtD
Glycine—Tachycardia—Docetaxel—melanoma	0.000109	0.00704	CcSEcCtD
Glycine—Vomiting—Temozolomide—melanoma	0.000106	0.00689	CcSEcCtD
Glycine—Hypotension—Docetaxel—melanoma	0.000104	0.00674	CcSEcCtD
Glycine—Nausea—Carmustine—melanoma	0.000103	0.00666	CcSEcCtD
Glycine—Nausea—Temozolomide—melanoma	9.94e-05	0.00644	CcSEcCtD
Glycine—Pain—Docetaxel—melanoma	9.52e-05	0.00617	CcSEcCtD
Glycine—Hypersensitivity—Docetaxel—melanoma	8.2e-05	0.00531	CcSEcCtD
Glycine—Diarrhoea—Docetaxel—melanoma	7.62e-05	0.00493	CcSEcCtD
Glycine—Dizziness—Docetaxel—melanoma	7.36e-05	0.00477	CcSEcCtD
Glycine—Vomiting—Docetaxel—melanoma	7.08e-05	0.00458	CcSEcCtD
Glycine—Nausea—Docetaxel—melanoma	6.61e-05	0.00428	CcSEcCtD
Glycine—GPR18—GPCR downstream signaling—CXCL8—melanoma	3.43e-05	0.000161	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ALB—melanoma	3.42e-05	0.00016	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—melanoma	3.41e-05	0.00016	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT3—melanoma	3.41e-05	0.00016	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EDN1—melanoma	3.4e-05	0.000159	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ALB—melanoma	3.4e-05	0.000159	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNA11—melanoma	3.32e-05	0.000156	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CSF2—melanoma	3.32e-05	0.000156	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF1—melanoma	3.32e-05	0.000156	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MDM2—melanoma	3.3e-05	0.000154	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—melanoma	3.27e-05	0.000153	CbGpPWpGaD
Glycine—SHMT1—Metabolism—FASN—melanoma	3.25e-05	0.000152	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—E2F1—melanoma	3.25e-05	0.000152	CbGpPWpGaD
Glycine—GSS—Metabolism—GNA11—melanoma	3.24e-05	0.000152	CbGpPWpGaD
Glycine—AGXT—Metabolism—PRKCA—melanoma	3.24e-05	0.000152	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CB—melanoma	3.24e-05	0.000152	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PDGFRA—melanoma	3.22e-05	0.000151	CbGpPWpGaD
Glycine—AGXT—Metabolism—ERCC2—melanoma	3.21e-05	0.000151	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC5A5—melanoma	3.2e-05	0.00015	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ITGB3—melanoma	3.19e-05	0.000149	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PRKCA—melanoma	3.19e-05	0.000149	CbGpPWpGaD
Glycine—GSS—Metabolism—FASN—melanoma	3.17e-05	0.000149	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	3.14e-05	0.000147	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PRKCA—melanoma	3.14e-05	0.000147	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SPP1—melanoma	3.12e-05	0.000146	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC5A5—melanoma	3.12e-05	0.000146	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAP2K2—melanoma	3.11e-05	0.000146	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ERCC2—melanoma	3.11e-05	0.000146	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—melanoma	3.11e-05	0.000146	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—melanoma	3.09e-05	0.000145	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CD44—melanoma	3.09e-05	0.000145	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNAQ—melanoma	3.09e-05	0.000145	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—melanoma	3.03e-05	0.000142	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CB—melanoma	3.02e-05	0.000141	CbGpPWpGaD
Glycine—GSS—Metabolism—CD44—melanoma	3.01e-05	0.000141	CbGpPWpGaD
Glycine—GSS—Metabolism—GNAQ—melanoma	3.01e-05	0.000141	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB4—melanoma	3.01e-05	0.000141	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—melanoma	2.99e-05	0.00014	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—melanoma	2.99e-05	0.00014	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.99e-05	0.00014	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CG—melanoma	2.98e-05	0.00014	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CG—melanoma	2.98e-05	0.00014	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CG—melanoma	2.98e-05	0.00014	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CG—melanoma	2.98e-05	0.00014	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN2B—melanoma	2.98e-05	0.00014	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—melanoma	2.97e-05	0.000139	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1B1—melanoma	2.96e-05	0.000139	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—melanoma	2.96e-05	0.000139	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RAC1—melanoma	2.95e-05	0.000138	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAPK1—melanoma	2.95e-05	0.000138	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—melanoma	2.94e-05	0.000138	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAPK1—melanoma	2.94e-05	0.000138	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1B1—melanoma	2.89e-05	0.000135	CbGpPWpGaD
Glycine—SHMT1—Disease—CD86—melanoma	2.88e-05	0.000135	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—melanoma	2.88e-05	0.000135	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—melanoma	2.88e-05	0.000135	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—melanoma	2.88e-05	0.000135	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—melanoma	2.88e-05	0.000135	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—melanoma	2.87e-05	0.000134	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—melanoma	2.85e-05	0.000133	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—melanoma	2.83e-05	0.000133	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF1—melanoma	2.8e-05	0.000131	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—melanoma	2.79e-05	0.000131	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PRKCA—melanoma	2.76e-05	0.000129	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—melanoma	2.75e-05	0.000129	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ERCC2—melanoma	2.73e-05	0.000128	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—melanoma	2.71e-05	0.000127	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRA—melanoma	2.71e-05	0.000127	CbGpPWpGaD
Glycine—SHMT1—Disease—PRKCA—melanoma	2.68e-05	0.000126	CbGpPWpGaD
Glycine—SHMT1—Disease—ERCC2—melanoma	2.66e-05	0.000125	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—melanoma	2.62e-05	0.000123	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—melanoma	2.62e-05	0.000123	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—melanoma	2.62e-05	0.000123	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—melanoma	2.62e-05	0.000123	CbGpPWpGaD
Glycine—SHMT1—Disease—MAP2K2—melanoma	2.62e-05	0.000123	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FN1—melanoma	2.61e-05	0.000122	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—melanoma	2.61e-05	0.000122	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—melanoma	2.59e-05	0.000121	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—melanoma	2.59e-05	0.000121	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—melanoma	2.59e-05	0.000121	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—melanoma	2.59e-05	0.000121	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.58e-05	0.000121	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH1—melanoma	2.55e-05	0.00012	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—melanoma	2.54e-05	0.000119	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CD80—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—melanoma	2.5e-05	0.000117	CbGpPWpGaD
Glycine—SHMT1—Disease—HLA-A—melanoma	2.49e-05	0.000117	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—melanoma	2.49e-05	0.000117	CbGpPWpGaD
Glycine—SHMT1—Disease—RAC1—melanoma	2.49e-05	0.000117	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—melanoma	2.47e-05	0.000116	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGF—melanoma	2.47e-05	0.000116	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—melanoma	2.46e-05	0.000115	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—melanoma	2.45e-05	0.000115	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—melanoma	2.44e-05	0.000114	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—melanoma	2.39e-05	0.000112	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—melanoma	2.38e-05	0.000112	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—melanoma	2.38e-05	0.000111	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—melanoma	2.37e-05	0.000111	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—melanoma	2.37e-05	0.000111	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—melanoma	2.36e-05	0.000111	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—melanoma	2.35e-05	0.00011	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—melanoma	2.29e-05	0.000107	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—melanoma	2.29e-05	0.000107	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—melanoma	2.29e-05	0.000107	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—melanoma	2.29e-05	0.000107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—melanoma	2.29e-05	0.000107	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK1—melanoma	2.27e-05	0.000107	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—melanoma	2.27e-05	0.000107	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—melanoma	2.27e-05	0.000106	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—melanoma	2.27e-05	0.000106	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—melanoma	2.27e-05	0.000106	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—melanoma	2.27e-05	0.000106	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAPK1—melanoma	2.25e-05	0.000106	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PRKCA—melanoma	2.25e-05	0.000105	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—melanoma	2.23e-05	0.000105	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ERCC2—melanoma	2.23e-05	0.000104	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAP2K1—melanoma	2.21e-05	0.000104	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—melanoma	2.2e-05	0.000103	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—melanoma	2.19e-05	0.000103	CbGpPWpGaD
Glycine—GSS—Metabolism—PRKCA—melanoma	2.19e-05	0.000103	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—melanoma	2.18e-05	0.000102	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—melanoma	2.17e-05	0.000102	CbGpPWpGaD
Glycine—GSS—Metabolism—ERCC2—melanoma	2.17e-05	0.000102	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—melanoma	2.17e-05	0.000102	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—melanoma	2.16e-05	0.000101	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—melanoma	2.16e-05	0.000101	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—melanoma	2.16e-05	0.000101	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—melanoma	2.15e-05	0.000101	CbGpPWpGaD
Glycine—SHMT1—Disease—NOTCH1—melanoma	2.15e-05	0.000101	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—melanoma	2.13e-05	0.0001	CbGpPWpGaD
Glycine—SHMT1—Disease—CD80—melanoma	2.1e-05	9.86e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF2—melanoma	2.1e-05	9.85e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—melanoma	2.1e-05	9.84e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—melanoma	2.1e-05	9.84e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—melanoma	2.08e-05	9.76e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGF—melanoma	2.08e-05	9.73e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—melanoma	1.98e-05	9.26e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—melanoma	1.98e-05	9.26e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—melanoma	1.98e-05	9.26e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—melanoma	1.98e-05	9.26e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—melanoma	1.97e-05	9.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—melanoma	1.97e-05	9.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—melanoma	1.97e-05	9.21e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—melanoma	1.94e-05	9.11e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—melanoma	1.94e-05	9.08e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—melanoma	1.93e-05	9.06e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—melanoma	1.93e-05	9.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—melanoma	1.91e-05	8.96e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—melanoma	1.9e-05	8.89e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—melanoma	1.89e-05	8.84e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—melanoma	1.88e-05	8.83e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—melanoma	1.87e-05	8.78e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—melanoma	1.87e-05	8.75e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAP2K1—melanoma	1.86e-05	8.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—melanoma	1.85e-05	8.65e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—melanoma	1.84e-05	8.63e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—melanoma	1.84e-05	8.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—melanoma	1.84e-05	8.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—melanoma	1.83e-05	8.56e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—melanoma	1.81e-05	8.48e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—melanoma	1.79e-05	8.41e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—melanoma	1.78e-05	8.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF2—melanoma	1.77e-05	8.29e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—melanoma	1.76e-05	8.24e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—melanoma	1.76e-05	8.24e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—melanoma	1.76e-05	8.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—melanoma	1.75e-05	8.19e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—melanoma	1.71e-05	8.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—melanoma	1.71e-05	8.02e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—melanoma	1.7e-05	7.96e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—melanoma	1.7e-05	7.95e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—melanoma	1.68e-05	7.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—melanoma	1.66e-05	7.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—melanoma	1.66e-05	7.76e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—melanoma	1.65e-05	7.75e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—melanoma	1.65e-05	7.75e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—melanoma	1.65e-05	7.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—melanoma	1.65e-05	7.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKB1—melanoma	1.64e-05	7.71e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—melanoma	1.64e-05	7.68e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—melanoma	1.63e-05	7.64e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—melanoma	1.63e-05	7.63e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—melanoma	1.61e-05	7.56e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—melanoma	1.61e-05	7.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—melanoma	1.61e-05	7.53e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—melanoma	1.59e-05	7.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—melanoma	1.55e-05	7.25e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—melanoma	1.53e-05	7.15e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—melanoma	1.51e-05	7.08e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—melanoma	1.51e-05	7.06e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—melanoma	1.5e-05	7.04e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—melanoma	1.49e-05	7e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—melanoma	1.49e-05	6.97e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—melanoma	1.48e-05	6.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—melanoma	1.47e-05	6.91e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—melanoma	1.43e-05	6.7e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—melanoma	1.43e-05	6.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—melanoma	1.41e-05	6.62e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—melanoma	1.39e-05	6.53e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—melanoma	1.39e-05	6.53e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—melanoma	1.39e-05	6.53e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—melanoma	1.39e-05	6.53e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—melanoma	1.39e-05	6.53e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—melanoma	1.39e-05	6.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—melanoma	1.37e-05	6.44e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—melanoma	1.35e-05	6.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK1—melanoma	1.34e-05	6.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—melanoma	1.34e-05	6.3e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—melanoma	1.34e-05	6.26e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—melanoma	1.33e-05	6.23e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—melanoma	1.31e-05	6.16e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—melanoma	1.3e-05	6.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—melanoma	1.27e-05	5.95e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—melanoma	1.24e-05	5.83e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—melanoma	1.24e-05	5.82e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—melanoma	1.19e-05	5.57e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—melanoma	1.19e-05	5.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—melanoma	1.17e-05	5.46e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—melanoma	1.16e-05	5.46e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—melanoma	1.16e-05	5.42e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—melanoma	1.15e-05	5.38e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—melanoma	1.14e-05	5.34e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—melanoma	1.14e-05	5.34e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—melanoma	1.14e-05	5.34e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—melanoma	1.14e-05	5.34e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—melanoma	1.14e-05	5.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK1—melanoma	1.13e-05	5.3e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—melanoma	1.13e-05	5.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—melanoma	1.13e-05	5.29e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—melanoma	1.09e-05	5.09e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—melanoma	1.08e-05	5.05e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—melanoma	1.07e-05	5.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—melanoma	1.03e-05	4.84e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—melanoma	1.01e-05	4.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—melanoma	9.81e-06	4.6e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—melanoma	9.68e-06	4.54e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—melanoma	9.52e-06	4.46e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—melanoma	9.38e-06	4.4e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—melanoma	9.08e-06	4.25e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—melanoma	8.69e-06	4.07e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—melanoma	8.23e-06	3.86e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—melanoma	8.22e-06	3.85e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—melanoma	8.02e-06	3.76e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—melanoma	8.01e-06	3.75e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—melanoma	6.71e-06	3.15e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—melanoma	6.54e-06	3.07e-05	CbGpPWpGaD
